연구

연구업적

최근 5년 연구업적 현황
연도 2025년 2024년 2023년 2022년 2021년
SCI 논문
발표편수
책임 196편 179편 173편 163편 184편
공동 132편 147편 120편 115편 136편
합계 328편 326편 293편 278편 320편
2195. Immunogenicity of influenza vaccination in patients with cancer receiving immune checkpoint inhibitor.
Keam B1,2, Kang CK1, Jun KI1, Moon SM3, Suh KJ3, Lee DW1,2, Ock CY1,2, Kim M1,2, Choi Y4, Lim Y1,2, Lee KH1,2, Kim SH3, Kim TM1,2, Kim TY1,2, Oh DY1,2, Kim DW1,2, Im SA1,2, Lee JS3, Kim ES3, Kim HB3, Kim NJ1, Kim YJ3, Park WB1, Oh MD1.
Clin Infect Dis. 2019 Nov 4. pii: ciz1092. doi: 10.1093/cid/ciz1092. [Epub ahead of print] Link
2194. Alterations in PD-L1 Expression Associated with Acquisition of Resistance to ALK Inhibitors in ALK-Rearranged Lung Cancer.
Kim SJ1, Kim S1, Kim DW1,2,3, Kim M1,2, Keam B1,2, Kim TM1,2, Lee Y1, Koh J4, Jeon YK4,5, Heo DS1,2,3
Cancer Res Treat. 2019 Jul;51(3):1231-1240. doi: 10.4143/crt.2018.486. Epub 2018 Dec 31. Link
2193. Interstitial Lung Abnormalities: Poor Prognosis for Patients with Lung Cancer
Goo JM
Radiology. 2019 Aug;292(2):499-500 Link
2192. Effect of Reconstruction Parameters on the Quantitative Analysis of Chest Computed Tomography
Kim H, Goo JM, Ohno Y, Kauczor HU, Hoffman EA, Gee JC, van Beek EJR.
J Thorac Imaging. 2019 Mar;34(2):92-102. Link
2191. Implication of total tumor size on the prognosis of patients with clinical stage IA lung adenocarcinomas appearing as part-solid nodules: Does only the solid portion size matter?
Kim H, Goo JM, Suh YJ, Park CM, Kim YT
Eur Radiol. 2019 Mar;29(3):1586-1594 Link
2190. Identification of a Novel Fusion Gene, FAM174A-WWC1, in Early-Onset Colorectal Cancer: Establishment and Characterization of Four Human Cancer Cell Lines from Early-Onset Colorectal Cancers.
Kim SC1, Shin R2, Seo HY1, Kim M3, Park JW3, Jeong SY4, Ku JL5.
Transl Oncol. 2019 Sep;12(9):1185-1195. doi: 10.1016/j.tranon.2019.05.019. Epub 2019 Jun 20. Link
2189. Establishment and Characterization of 10 Human Pancreatic Cancer Cell Lines Including a HER2 Overexpressed Cell Line.
Kim SC1,2, Shin YK1, Kim SW3,4, Seo HY1,2, Kwon W3,4, Kim H3,4, Han Y3,4, Lee JO1, Jang JY3,4, Ku JL1,2.
Pancreas. 2019 Nov/Dec;48(10):1285-1293. doi: 10.1097/MPA.0000000000001420. Link
2188. Successful preemptive therapy with single-dose rituximab for Epstein-Barr virus infection to prevent post-transplant lymphoproliferative disease after pediatric hematopoietic stem cell transplantation.
Kim BK, Kang HJ, Hong KT, An HY, Choi JY, Lee JS, Park SS, Shin HY.
Transpl Infect Dis.21(6):e13182. Link
2187. Tandem high-dose chemotherapy with topotecan-thiotepa-carboplatin and melphalan-etoposide-carboplatin regimens for pediatric high-risk brain tumors.
Choi JY, Kang HJ, Hong KT, Hong CR, Lee YJ, Park JD, Phi JH, Kim SK, Wang KC, Kim IH, Park SH, Choi YH, Cheon JE, Park KD, Shin HY.
Int J Clin Oncol.24(12):1515-1525. Link
2186. Successful Treatment of Pediatric Epstein-Barr Virus-positive Aggressive Natural Killer-Cell Leukemia.
Kim BK, Hong KT, Kang HJ, An HY, Choi JY, Hong CR, Park KD, Lee DS, Shin HY.
J Pediatr Hematol Oncol.41(5):e336-e337. Link